STROKE PREVENTION IN ELDERLY PEOPLE
However, its effective use is hampered by several challenges, including the attended bleeding risk, noncompliance, and cost.
Elderly patients are further disadvantaged with additional factors that may limit the use of OAC, such as frailty, polypharmacy, and functional dependence. In addition, there are limited data to guide stroke prevention decisions in these patients; octogenarians are typically excluded from clinical trials, and observational data specific to their age group are sparse. Nonetheless, AF continues to be a major and increasing cause of stroke and disability in this population. In a nationwide US survey, more than 40% of patients aged 85 years and older admitted with ischemic stroke in 2014 had AF.With the rising prevalence of AF in the ever-growing elderly populations worldwide, efforts to bridge this knowledge gap are welcomed.
Q.The paragraph says that
A)OAC is the best method of treatment for stroke prevention
B)No enough data to support use of OAC in Stroke prevention
C) cost of medication is effecting use of OAC in AF patients.